GB1567444A - Preparation of substituted succinic acid esters - Google Patents
Preparation of substituted succinic acid esters Download PDFInfo
- Publication number
- GB1567444A GB1567444A GB827178A GB827178A GB1567444A GB 1567444 A GB1567444 A GB 1567444A GB 827178 A GB827178 A GB 827178A GB 827178 A GB827178 A GB 827178A GB 1567444 A GB1567444 A GB 1567444A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acetyl
- process according
- methyl
- diester
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 68
- 238000000034 method Methods 0.000 claims description 47
- 239000002585 base Substances 0.000 claims description 36
- -1 iodide ions Chemical class 0.000 claims description 36
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 35
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 28
- 150000002148 esters Chemical class 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 24
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 22
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- CMXNFXBFNYHFAL-UHFFFAOYSA-N 5-methylhex-1-en-3-one Chemical compound CC(C)CC(=O)C=C CMXNFXBFNYHFAL-UHFFFAOYSA-N 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 150000005690 diesters Chemical class 0.000 claims description 14
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
- 239000002798 polar solvent Substances 0.000 claims description 12
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 7
- WXUAQHNMJWJLTG-UHFFFAOYSA-N 2-methylbutanedioic acid Chemical compound OC(=O)C(C)CC(O)=O WXUAQHNMJWJLTG-UHFFFAOYSA-N 0.000 claims description 6
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 6
- 230000003197 catalytic effect Effects 0.000 claims description 5
- 239000001384 succinic acid Substances 0.000 claims description 5
- NZZYVDKRZFWNRJ-UHFFFAOYSA-M 2-chloro-2-methylbutanoate Chemical compound CCC(C)(Cl)C([O-])=O NZZYVDKRZFWNRJ-UHFFFAOYSA-M 0.000 claims description 4
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002168 alkylating agent Substances 0.000 claims description 4
- 229940100198 alkylating agent Drugs 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000007790 solid phase Substances 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 12
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 11
- 239000000543 intermediate Substances 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 235000011181 potassium carbonates Nutrition 0.000 description 11
- 229960001680 ibuprofen Drugs 0.000 description 10
- 235000007715 potassium iodide Nutrition 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 5
- 238000005804 alkylation reaction Methods 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 238000006957 Michael reaction Methods 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 4
- 229940006461 iodide ion Drugs 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 150000003839 salts Chemical group 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 150000003900 succinic acid esters Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229910001868 water Inorganic materials 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical compound C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 3
- BCCSQROBARTQRV-UHFFFAOYSA-N 1-(diethylamino)-5-methylhexan-3-one Chemical compound CCN(CC)CCC(=O)CC(C)C BCCSQROBARTQRV-UHFFFAOYSA-N 0.000 description 2
- MONMFXREYOKQTI-UHFFFAOYSA-M 2-bromopropanoate Chemical compound CC(Br)C([O-])=O MONMFXREYOKQTI-UHFFFAOYSA-M 0.000 description 2
- GAWAYYRQGQZKCR-UHFFFAOYSA-N 2-chloropropionic acid Chemical compound CC(Cl)C(O)=O GAWAYYRQGQZKCR-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 238000005956 quaternization reaction Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- JEGMBBOTTAQDLR-UHFFFAOYSA-L (4-methylphenyl)-di(undecyl)sulfanium;sulfate Chemical compound [O-]S([O-])(=O)=O.CCCCCCCCCCC[S+](CCCCCCCCCCC)C1=CC=C(C)C=C1.CCCCCCCCCCC[S+](CCCCCCCCCCC)C1=CC=C(C)C=C1 JEGMBBOTTAQDLR-UHFFFAOYSA-L 0.000 description 1
- WXUAQHNMJWJLTG-VKHMYHEASA-N (S)-methylsuccinic acid Chemical class OC(=O)[C@@H](C)CC(O)=O WXUAQHNMJWJLTG-VKHMYHEASA-N 0.000 description 1
- XZXYQEHISUMZAT-UHFFFAOYSA-N 2-[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound CC1=CC=C(O)C(CC=2C(=CC=C(C)C=2)O)=C1 XZXYQEHISUMZAT-UHFFFAOYSA-N 0.000 description 1
- GNOLNOYLZKIGIJ-UHFFFAOYSA-N 2-[4-(2-methylpropyl)-2-oxocyclohex-3-en-1-yl]propanoic acid Chemical compound CC(C)CC1=CC(=O)C(C(C)C(O)=O)CC1 GNOLNOYLZKIGIJ-UHFFFAOYSA-N 0.000 description 1
- OAAGDVLVOKMRCQ-UHFFFAOYSA-N 5-piperidin-4-yl-3-pyridin-4-yl-1,2,4-oxadiazole Chemical compound C1CNCCC1C1=NC(C=2C=CN=CC=2)=NO1 OAAGDVLVOKMRCQ-UHFFFAOYSA-N 0.000 description 1
- 101100453572 Arabidopsis thaliana KCO3 gene Proteins 0.000 description 1
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 238000006683 Mannich reaction Methods 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 101100453573 Oryza sativa subsp. japonica TPKC gene Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 1
- 229910001619 alkaline earth metal iodide Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940107816 ammonium iodide Drugs 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 229910001640 calcium iodide Inorganic materials 0.000 description 1
- 229940046413 calcium iodide Drugs 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- KDMUHZGJBPCVBU-UHFFFAOYSA-N dimethyl(phenyl)sulfanium;nitrate Chemical compound [O-][N+]([O-])=O.C[S+](C)C1=CC=CC=C1 KDMUHZGJBPCVBU-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- JFKRJMSTDGAFPN-UHFFFAOYSA-N ethyl 1-(1-ethoxy-1-oxopropan-2-yl)-4-(2-methylpropyl)-2-oxocyclohex-3-ene-1-carboxylate Chemical compound CCOC(=O)C(C)C1(C(=O)OCC)CCC(CC(C)C)=CC1=O JFKRJMSTDGAFPN-UHFFFAOYSA-N 0.000 description 1
- LPJWUGWDBWLPKG-UHFFFAOYSA-N ethyl 2-[4-(2-methylpropyl)-2-oxocyclohex-3-en-1-yl]propanoate Chemical compound CCOC(=O)C(C)C1CCC(CC(C)C)=CC1=O LPJWUGWDBWLPKG-UHFFFAOYSA-N 0.000 description 1
- ARFLASKVLJTEJD-UHFFFAOYSA-N ethyl 2-bromopropanoate Chemical compound CCOC(=O)C(C)Br ARFLASKVLJTEJD-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- PUYARGANLIIOJG-UHFFFAOYSA-L methyl(triphenyl)phosphanium;sulfate Chemical compound [O-]S([O-])(=O)=O.C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1.C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 PUYARGANLIIOJG-UHFFFAOYSA-L 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- IBWGNZVCJVLSHB-UHFFFAOYSA-M tetrabutylphosphanium;chloride Chemical compound [Cl-].CCCC[P+](CCCC)(CCCC)CCCC IBWGNZVCJVLSHB-UHFFFAOYSA-M 0.000 description 1
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical class SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
- XQLLUORERPKHEM-UHFFFAOYSA-M trimethyl(phenyl)phosphanium;iodide Chemical compound [I-].C[P+](C)(C)C1=CC=CC=C1 XQLLUORERPKHEM-UHFFFAOYSA-M 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
(54) THE PREPARATION OF SUBSTITUTED SUCCINIC ACID ESTERS
(71) We, THE UPJOHN COMPANY, a corporation organized and existing under the laws of the State of Delaware, United States of America, of 301 Henrietta Street,
Kalamazoo, State of Michigan, United States of America, do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:
This invention relates to processes for preparing derivatives of succinic acid esters, and to the use of those succinate ester derivatives in processes for making useful acid compounds.
More particularly, this invention provides an improved process for preparing esters of a-acetyl-a'-methylsuccinic acid, which are useful as intermediates for preparing esters of o-methyl-a'-acetyl-a'-(5-methyl-3-oxohexyl)succinic acid esters which are known to be useful in processes for preparing useful drug acids such as flubriprofen and ibuprofen, i.e.
2-(p-isobutylphenyl)propionic acid.
It is known that diethyl a-acetyl-a'-methylsuccinate can be prepared in about 63 percent yield by reacting ethyl acetoacetate with ethyl a-bromopropionate in the presence of sodium hydroxide, potassium iodide and water. See Chem. Abs. 62, 13037c abstracting (Zh. Pukl. Khim, 38(2), pp 436-7 (1965). Also, J. Chem. Soc. (London), 4633-40 (1970) reports that this same diester can be prepared in about 47 percent yield by reacting ethyl acetoacetate with ethyl ct-bromopropionate in the presence of sodium in ethanol. Similar disclosures are found at Chem. Abs. 54, 10852h: Chem. Abs. 49. 1565c of J. Chem. Soc.
(London) 3313 (1953); and Chem. Abs. 38, 2332 of J. Ind. Chem. Soc., 20, 173-7 (1943).
However, it has been found in the studies when led to this invention that neither the aqueous basic system nor the ethanolic basic systems allowed the above alkylation to occur with the less expensive ethyl 2-chloropropionate in place of the ethyl 2-bromopropionate.
We have found that, using the 2-chloropropionate ester at moderate temperatures 400-500C.), no significant alkylation reaction occurs; under more vigorous conditions higher temperature), using these base systems, 2-chloropropionate and acetoacetate ester starting materials are consumed but little diethyl a-acetyl-a-methyl-succinate ester accumulates in the product, evidence that this valuable succinate ester intermediate is somewhat unstable and is converted to undesired. useless by-products in the reaction mixture.
According to the present invention, a process for preparing a diester of a-acetyl-a'methylsuccinic acid comprises reacting a mixture of an ester of acetoacetic acid and an ester of a-chloropropionic or a-bromo-propionic acid at a temperature of from 50"C to the reflux temperature of the mixture in a substantially non-polar. aprotic organic liquid having a dielectric constant below 11 at 25"C., in the presence of (i) a solid deprotonating base having a surface area equivalent to a size no larger than 60 mesh. (ii) a solid/liquid phase transfer catalyst and (iii) a catalytic amount of iodide ions.
The reaction mixture resulting from the process of the invention can be used per se in further chemical processing steps to contact and react the a-acetyl-a'-methylsuccinate ester content thereof with vinyl isobutyl ketone (or the corresponding Mannich base in the presence of an alkylating agent) and an alkali metal base in a polar solvent to form a diester of a-methyl-a'-acetyl-a'-(5-methyl-3-oxohexyl)-succinic acid which is a non-cyclic aliphatic precursor to iboprofen, which is obtained by heat treatment according to procedures known in the art. See, for example, British Patent Specification No. 1.265.800. Belgian Patent
Specification No. 820,267, or U.S. Patent Specification No. 4.008.270.
In one particularly preferred embodiment of the process of this invention, ethyl acetoacetate and ethyl a-chloro-propionate or ethyl a-bromopropionate are heated together at 90 to 1100C in a liquid medium containing benzene, toluene or xylene in the presence of potassium carbonate, potassium iodide and tetrabutylammonium bromide, to form diethyl a-acetyl-a'-methylsuccinate.
In a second particularly preferred embodiment of the process of this invention, ethyl chloropropionate is reacted with ethyl acetoacetate in toluene at 75 to 80"C in the presence of tricaprylyl methylammonium chloride (as phase transfer agent), potassium iodide (as a source of iodide ions) and potassium carbonate, milled to a size below 80 mesh (as deprotonating base), to form diethyl a-acetyl-a'-methylsuccinate.
It has been found that the process of this invention can provide the stabilising basic conditions needed for the formation of the o-acetyl-a'-methylsuccinate diester from the more economical 2-chloropropionate esters. For example, it has been found that under otherwise identical conditions i.e. 78"C., K2CO3 as base, potassium iodide, (KI) as iodide ion source, and Aliquat 336 as phase transfer agent. the diethyl cr-acetyl-cr'-methylsuccinate has a half-life of about 2 hours in absolute ethanol; in toluene (as used in this invention) the half-life of this diester is extended to over 70 hours. Thus, we have found that alkylation of the acetoacetate ester with the 2-bromopropionate or 2-chloropropionate ester in toluene or heptane (or an equivalent non-polar liquid organic medium), using dry, milled alkali metal carbonate, a phase transfer catalyst and potassium iodide gives over 70 percent yield of the a-acetyl-a'-methylsuccinate diester with only 2.6 percent of o-alkylation and 2.9 percent formation of enol-lactone by-products. Using solvents such as methylene chloride for this process results in the formation of a reduced amount of a-acetyl-a'-methylsuccinate ester product contaminated with from 20 to 30 percent of o-alkylated material of the formula AlkOOC-CH(CH3)-O-C(CH3)=CH-COOAlk where Alk denotes the alkyl ester group, e.g., ethyl. which does not separate easily, and the ester terminated chains are in cis-configuration with respect to the double bond. It is best practice of the process of this invention to make the alkylation of the acetoacetate ester with the 2-bromopropionate or 2-chloropropionate ester to form the a-acetyl-a'-methylsuccinate diester as complete as possible.
Thus, the above chemistry provides an improved, practical chemical process by which important 2-aryl-alkanoic acid drug and agriculturally significant esters and acids therefrom can be prepared swiftly from inexpensive aliphatic component chemicals.
The acetoacetic acid ester starting materials are known compounds and the particular ester is not critical. See for example British Patent Specification No. 1.265.800. The ester should be one which is soluble in the substantially nonpolar. organic liquid medium. The C16 esters are preferred and the ethyl ester is more particularly preferred. Also. the a-bromopropionate and a-chloropropionate esters starting materials are known compounds, and the particular ester group is not critical but should be one which makes the ester compound soluble enough in the substantially nonpolar organic liquid solvent medium to react. The C, to C6-alkyl esters. and particularly the ethyl ester. are preferred.
The substantially nonpolar organic liquids function as solvents for the ester reactants in the process of this invention and are organic liquid compounds or mixtures thereof which have dielectric constants of below 11, and preferably below 5, at 25"C. See. e.g., Lange's Handbook of Chemistry, 9th Edition, (1956). pp 1222-1225. Examples of solvent liquids for this purpose includes benzene, toluene. xylene. cyclohexane. heptane. nonane. chloroform and bromobenzene. The preferred nonpolar. aprotic solvent for use herein is toluene and mixtures thereof.
The solid/liquid phase transfer agents are generally quaternary ammonium. sulfonium or phosphonium salts which function to assist contact between the solid and liquid materials in the mixture. Examples of such phase transfer agents include the tetra (C16 alkyl)ammonium halides such as tetrabutylammonium bromide. and other known quaternary salts available for this purpose. as well as crown ethers. e.g.. those described in U.S.Patent
Specification No. 4,001.279. as well as the patent references cited therein, and sulfonium (R3S) salts such as the tris(C~s alkyl)sulfonium acid di(C~s alkyl) phenyl-sulfonium salts, e.g., trimethvlsulfonium iodide. trisdodecylsulfonium sulfate, dioctodecylmethylsulfonium chloride, dimethylphenylsulfonium nitrate and diundecyl-p-toluylsulfonium sulfate, and phosphonium (R4P+) salts such as the tetra (CI--18 alkyl) phosphonium and mixed alkyl arylphosphonium salts such as tetrabutylphosphonium chloride. trimethylphenylphosphonium iodide, methyl triphenylphosphonium sulfate. and the like. A commercially available example of such a phase transfer agent is sold under the trade name i Aliquat 336" which is believed to be tricaprylyl methylammonium chloride.
The iodide ion can be provided in any economical, soluble form in at least a catalytic amount. Alkali metal iodide salts such as sodium and potassium iodides are preferred.
Ammonium iodide, and alkaline earth metal iodides such as calcium iodide, could also be used but are less preferred for reasons of cost and less efficiency with them. It can also be supplied by the iodide ion of a phase transfer agent salt, above. The catalytic amount of iodide ion can be a small amount, less than molar proportion to the ester reactants.
The deprotonating base, such as alkali metal carbonates, orthophosphates, C16 alkoxides and hydroxides (as opposed to Lewis bases generally), is preferably present in an amount at least about stoichiometrically equivalent to each of the ester reactants. The deprotonating base is preferably oven dried to remove at least most of any adhering water therefrom. It can be provided as a finely milled powder, below 60 mesh, and preferably below 100 mesh. or in some other high surface area contact for equivalent in surface area thereto, such as in highly porous pressed composite granules, tablets or pellets. which will act as the deprotonating base in these reaction mixtures.
The reaction mixture of the above ingredients is stirred or otherwise agitated to provide efficient contact of the liquid and solid components of the mixture for a time sufficient to effect as complete a reaction as is efficiently possible. At temperatures below 50"C., the reaction times are generally too slow to be acceptable for commercial scale operations.
Stirring the mixture for about six hours at about 75"-100"C. is generally about the optimum time and temperature for most efficient yields when the ethyl esters of the reactants are being used.
The a'-acetyl-a'-methylsuccinate diester product can be recovered friom the reaction mixture by conventional means, if desired. but since it is usually contemplated to use these esters as intermediates for further reaction, such recovery is usually not necessary.
Another advantage of preparing the a-acetyl-a'-methyl-succinate ester in the manner described herein is that it allows for the simple preparation of the a-acetyl-a-(5-methyl-3osohexyl)-a'-methylsuccinate ester therefrom in the same vessel and solvent medium in which the a-acetyl-a'-methylsuccinate ester was prepared. The a'-acetyl-a'-(5-methyl-3- oxohexyl)-a-methylsuccinate ester is described in Belgian Patent Specification No. 820,267, and is an intermediate which can be prepared in processes for preparing ibuprofen, the anti-inflammatory drug. The process of this invention thus allows a complex chemical sequence to be carried out with minimum equipment and labour.
When ethyl acetoacetate is reacted with ethyl a-chloropropionate or ethyl abromopropionate in the presence of a deprotonating base (KCO3) and toluene. diethyl a-acetyl-a'-methylsuccinate and potassium chloride or potassium bromide are formed in solution. This solution may be reacted in either of two ways to form diethyl a-acetyl-a-(5 methyl-3-oxohexyl)-ct'-methylsuccinate. In the first method. isobutyl vinyl ketone. potassium hydroxide and a polar solvent are used. In the second method. N.N-diethyl-5-methyl3-oxohexylamine, dimethyl sulfate, additional potassium carbonate and a polar solvent are used.
The specific reactions described above for the preparation of the diethyl ester may be generalised for all esters and, as is preferred in this invention. for all C, 6 esters. In general, when the reaction of the acetoacetate ester and the a-halopropionate ester to form the a-acetyl-a'-methylsuccinate diester in solution is completed, the mixture containing the diester may be treated with either isobuytl vinyl ketone per se and base plus a polar solvent or an N,N-di(Cl~6 alkyl)-N-(5-methyl-3-oxohexyl)amine Mannich base precursor thereto
(prepared by known procedures from a dialkylamine, paraformaldehyde and isobutyl vinyl ketone) plus an alkylating agent such as a di(C16 alkyl)sulfate, e.g.. dimethylsulfate. or a C16 alkyl iodide, e.g., methyl iodide, and additional deprotonating base which serves to convert the alkylated Mannic base to isobutyl vinyl ketone ill situ as well as to catalyze the
Michael reaction between the isobutyl vinyl ketone and the a-acetyl-a' -methylsuccinate diester derivative in the presence of some added polar solvent. preferably a C16 alkanol or
an N,N-bis-(C16 alkyl)formamide.
When the Mannich base, e.g., N,N-diethyl-N-(5-methyl-3-oxohexyl)amine is added to the a-acetyl-a'-methyl-succinate diester to form the a-acetyl-a-(5-methyl-3-oxohexyl)-a'methylsuccinate diester, it is preferred to limit the additional deprotonating base, e.g., potassium carbonate, as closely as possible to not more than the amount which was used in the production of the a-acetyl-a'-methylsuccinate diester itself. This is because at high
(apparent) pH the a-acetyl-a'-methylsuccinate intermediate is 0-alkylated by the alkylating
agent, e.g., dimethylsulfate. When the isobutyl vinyl agent ketone is being generated in situ, dimethylsulfate is preferably added at low temperatures. say 0 to 5 ., to suppress
N,N-dialkyl-N-methylamine elimination which could occur at higher temperatures since it consumes dimethyl sulfate. Only after the Mannich base is quaternized and essentially
absent (as determined by gas liquid chromatogrophy or other equivalent analysis of samples
of the reaction mixture) is a more polar organic liquid solvent. preferably a C16 alkanol, e.g., ethanol, or an N,N-C16 to C6 - dialkylformamide. and more deprotonating base, e.g., potassium carbonate, or potassium hydroxide, added to initiate the Michael reaction between the Mannich base and the a-acetyl-a'-methylsuccinate diester. When added deprotonating base brings the aopparent pH to about 11.5, the Michael reaction will occur.
At about pH 13, aldolization (which is acceptable) will occur. Addition of the polar solvent such as a C1 to C6-alkanol, e.g., ethanol, is necessary for Michael reaction. The addition of the polar solvent, e.g., alcohol, is made after quaternization of the Mannich base is complete so that dimethyl sulfate is not consumed by the alcohol or other polar solvent. The size (surface area), dryness and stirring of the deprotonating base, e.g., potassium carbonate, is important to reproducibility of this heterogeneous reaction. Control of these quaternization, base addition and polar solvent addition factors is not difficult, however, once one is aware of the parameters discussed. We can predict to within about 1 percent the amount of deprotonating base required to attain the pH to start the Michael addition.
When the vinyl ketone intermediate, e.g., isobutyl vinyl ketone, used to make ibuprofen, is prepared by distillation or by pyrolysis of the Mannich base hydrochloride [see British
Patent Specification No. 1,265,800; Belgian Patent Specification No. 820,267; and
Tetrahedron Letters, 4739 (1968)l, the use of dimethyl sulfate is avoided. Distilled isobutyl vinyl ketone is also described by T.A. Spencer et al. "The Course of the Mannich Reaction with Methyl Isobutyl Ketone...." in J. Orq. Chem. 32 1234 (1967). When the isobutyl vinyl ketone or other vinyl ketone is used directly, a rapid and efficient base catalyst for use in this second step of the process is ethanolic potassium hydroxide which is added slowlv to the nonpolar solvent solution of the a-acetyl-a-'-methylsuccinate diester. The base, e.g., ethanolic potassium hydroxide, operates by converting the phase transfer agent. e.g.,
Aliquat 336 or tetrabutylammonium bromide. used in the preparation of the a-acetyl-a-'- methylsuccinate diester, to the quaternary ammonium hydroxide which promotes the formation of the non-cyclic Michael adduct, e.g., dialkyl -acetyl-a-(5-methyl-3-oxohexyl) Ct- '-methylsuccinate used in the production of ibuprofen.
Continued base treatment of the reaction mixture between the a-acetvl-a'- methylsuccinate diester and the isobutyl vinyl ketone to form the ct-acetyl-a-(5-methyl-3- oxohexyl)-ot'-methylsuccinate ester gives an aldol condensation to form the respective esters of 2-(4-isobutyl-2-oxo-cyclohex-3-enyl)propionic acid and u-methyl-ct-(4-isobutyl-2- oxo-cyclohex-3-enyl)- succinic acid. Both the esters and the corresponding acids are intermediates in the syntheses of iboprofen.
The non-cyclic diester of a-acetyl-a-(5-methyl-3-oxohexyl)-a'-methylsuccinic acids can be isolated by known methods such as extraction and distillation. This non-cyclic ester. and also the cylcic esters. or any combination thereof, and their free acids can then be used as intermediates to prepare ibuprofen. The intermediary of succinate diester for this purpose is implicit in British Patent Specification No. 1,265.800. and is explicit in Belgian Patent
Specification No. 820.267. In addition, improved processes for using the non-cyclic succinate diester as an intermediate to prepare ibuprofen are described in U.S. Patent
Specification No. 4,008,270 and in British Patent Application No. 30424/77 (Serial No.
1563877).
The invention is further described and exemplified by the following detailed Examples which are not intended to limit the scope of the invention.
Example 1.
Ethyl acetoacetate (75 mmoles. 9.51 ml.), ethyl a-chloropropionate (75 mmoles. 9.48 ml.), milled (about 100 mesh) potassium carbonate (13.8 g.). potassium iodide (1.0 g.), tetrabutylammoniumbromide (1.0 g.) and toluene (90 ml.) were placed in a 250 ml.
3-necked flask and stirred in a 100"C. bath for about 6 hours. Then a sample of the resulting reaction mixture was analyzed by the gas liquid chromatography (glc) assay method on a 6 foot. 2 percent OV 17 column and showed that 71.8 percent of the theoretical yield of diethyl a-methyl-a'-acetylsuccinate had been produced. This toluene solution of diethyl a-methvl-a'-acetylsuccinate is useful directly in processes for preparing other useful compounds such as ibuprofen which are known anti-inflammatory drug acid compounds.
Example 2
Preparation of diethyl a-acetyl-a'-methylsuccinate. and use of the reaction mixture of this ester to form diethvl o-methyl-a'-(5-methyl-3-oxohexyl)-a-acetylsuccinate A 1.0 g. portion of Aliquat 336 (tricaprylyl methyl ammonium chloride). 35.0 ml. of toluene, 9.51 ml. (75 mmole) of ethyl acetoacetate. 9.48 ml. (75 mmole) of ethyl chloropropionate. 1.0 g. ( < 60 mesh) of potassium iodide. and 100 milliequivalents. 13.8 g.
of less than 80 mesh. oven-dried potassium carbonate are placed in a 250 ml. 3-necked flask equipped with a condenser. mechanical stirrer and thermometer. The mixture is stirred at 7-8 C. for about 6 hours to ensure formation of diethyl a-acetyl-a'-methylsuccinate, without substantial decomposition by further heating.
Then 7.5 ml. of ethanol is added and the mixture is cooled to 0. C. Mannich base,
N,N-diethyl-N-(5-methyl-3-oxohexyl)amine, 90 percent pure, 20.0 ml., is added Diemthyl sulfate, 16.0 ml. (172 mmole) is added over 1.3 hours while controlling the temperature to below about 3"C. The mixture is stirred for 5 hours and 20 minutes as the temperature was allowed to rise gradually from 0 to 310C. in about 62 minutes and then cooled again to 20 to 24"C. over 4 hours while 8.8 g of potassium carbonate is added in four portions (at 24 minutes, 44 minutes, 1 hour and 10 minutes, and 1 hour and 40 minutes) from the reaction starting time. After overnight storage at -5 C. the mixture is stirred again at 15-20"C. for two hours to ensure as complete a reaction as possible.
For workup, the resulting reaction mixture is mixed with 50 ml. of water and the aqueous and organic phases were allowed to separate. The aqueous phase is washed with 40 ml. of toluene. The toluene phases are washed with two 35 ml. portions of saturated brine (NaCi) solution. Additional 3rd, 4th and 5th washes with saturated brine solution (22 ml. each) are also conducted to more completely neutralize the organic phase product mixture (the pH was lowered from 12.6 to 6.5 by these washes). These additional washes are not essential.
The toluene phases are combined, dried with sodium sulfate. concentrated and distilled.
The distillate is collected in five fractions; fractions 2, 3 and 4, b.p. 154-176 C., are taken as containing the product in a total weight of 19.074 g. for these fractions, or 5U.8 mmole (67.7 percent yield, based on ethyl acetoacetate), of diethyl a-methyl-a'-(5-methyl-3-oxohexyl)- a'-acetylsuccinate. Alternatively, crude non-distilled mixture product can be used directly in ibuprofen synthesis.
Example 3
Preparation of diethyl a-methyl-a'-acetyl-a'-(5-methyl-3-oxohexyl)succinate from diethyl a-acetyl-a'-methylsuccinate and prepared vinyl isobutyl ketone
To a 105.5 ml. (50 mmole) solution of diethvl a-acetyl-a'-methylsuccinate in toluene, prepared as described in Example 2 in a 250 ml. 3-necked flask there was added 28.0 ml.
(100 mmole) of vinyl isobutyl ketone in a 49.3 percent solution, 0.813 g./ml. Then 8.0 ml. of a 101 mg./ml. solution of potassium hydroxide (14.4 m equivalents) in ethanol was added.
The mixture was stirred for 6 hours at room temperature and then 2.5 ml. (4.5 m equivalents) of the same ethanolic potassium hydroxide solution was added and the reaction was allowed to continue for 4 more hours.
Saturated brine (25 ml.) and water (5 ml.) were added and the phases were separated.
The toluene phase was washed with brine (30 ml.) and then with brine (30 ml.) containing 0.27 g. of sodium bisulfate. Aqueous phases were backwashed in sequence with toluene (30 ml.). The combined toluene phases were dried over sodium sulfate. filtered and concentrated to an oil weighing 26.63 g. The oil was distilled and the distillate was collected in three fractions.
Oil Bath, Pressure
Fraction ( C.) B.P.( C.) (mm.Hq) Wt (q.) 1 < 100 < 50 0.30-0.32 0.183 2 < 160 90-128" 0.28-0.30 0.280 3 180-215 155-185 0.22-0.30 18.172
Analysis of fraction 3 by gas liquid chromotography showed that it contained (a) 7.59 mmole of ethyl 2-(4-isobutyl-2-oxo-cyclohex-3-enyl)propionate; (b) 23.30 mmole of diethyl a-methyl-a' -acetyl-a' (5-methyl-3-oxohexyl)-succinate: and (c) 11.94 mmole of ethyl 2-(4-isobutyl-2-oxo-1 -carboethoxy-cyclohexenyl )propionate. or a total of 42.89 mmole of 85.8 percent yield. A residue of 2.20 g. remained.
Each of these products (a), (b) and (c) (separately or in a mixture) in the fraction 3 mixture can be converted to the useful drug acid. ibuprofen. by known procedures. and thus the whole of fraction 3 would be used for that purpose.
Alternatively, the crude undistilled mixture of (a). (b) and (c) can be converted directly to ibuprofen by the heat treatment procedures referred to above.
In summary, this invention provides a process improvement in which a-acetyla'methylsuccinate esters can be produced in a stabilizing reaction medium which permits the use of mild conditions as well as the use of the less reactive a-chloropropionate esters as starting material. The process conditions favor the formation of the a-acetyl-a'methylsuccinate ester intermediates while minimizing its decomposition which lower yields of the desired a-acetyl-a'-methylsuccinate ester intermediates. and the desired products resulting therefrom.
WHAT WE CLAIM IS:
1. A process for preparing a diester of a-acetyl-cr'-methyl-succinic acid which comprises reacting a mixture of an ester of acetoacetic acid and an ester of a-chloropropionic or a-bromopropionic acid at a temperature of from 50"C to the reflux temperature of the mixture in a substantially nonpolar, aprotic organic liquid having a dielectric constant below
11 at 25 C., in the presence of (i) a solid deprotonating base having a surface area .equivalent to a size no larger than 60 mesh, (ii) a solid/liquid phase transfer catalyst and (iii) a catalytic amount of iodide ions.
2. A process according to claim 1 in which the nonpolar, aprotic organic liquid has a dielectric constant below 5 at 25"C.
3. A process according to either preceding claim in which each ester radical is a C1 -6 alkyl group.
4. A process according to claim 1 in which ethyl acetoacetate and ethyl Ct- chloropropionate or ethyl a-bromopropionate are heated together at 90 to 1100C in a liquid medium containing benzene, toluene or xylene in the presence of potassium carbonate, potassium iodide and tetrabutylammonium bromide. to form diethyl a-acetyl-a'- methylsuccinate.
5. A process according to claim 1 in which ethyl chloropropionate is reacted with ethyl acetoacetate in toluene at 75 to 80"C in the presence of tricaprylyl methylammonium chloride, potassium iodide, and potassium carbonate, milled to a size below 80 mesh, to form diethyl a-acetyl-a'-methylsuccinate.
6. A process according to claim 1 substantially as described in Example 1 or Example 2.
7. A diester of a-acetyl-a'methylsuccinic acid when prepared by a process according to any preceding claim.
8. A process for preparing a diester of a-methyl- '-acetyl-a'(5-methyl-3-oxohexyl) succinic acid which comprises reacting the cr-acetyl-a'-methylsuccinate diester prepared by a process according to any of claims 1 to 6 with isobutyl vinyl ketone and an alkali metal base in a polar solvent.
9. A process according to claim 8 in which a nonpolar. aprotic organic liquid containing
a di (Cl~,alkyl) ester of Ct-acetvl-ct'-methylsuccinate is reacted with vinyl isobutyl ketone
and a C16 alkanol solution of the base. to form a di(Cl alkyl)a-methyl-a'-(5-methyl-3- oxohexyl) succinate ester.
10. A process according to claim 9 in which a toluene solution of diethyl a-acetyl-a'- methvlsuccinate is reacted with vinyl isobutyl ketone and potassium hydroxide in ethanol
Claims (14)
1. A process for preparing a diester of a-acetyl-cr'-methyl-succinic acid which comprises reacting a mixture of an ester of acetoacetic acid and an ester of a-chloropropionic or a-bromopropionic acid at a temperature of from 50"C to the reflux temperature of the mixture in a substantially nonpolar, aprotic organic liquid having a dielectric constant below
11 at 25 C., in the presence of (i) a solid deprotonating base having a surface area .equivalent to a size no larger than 60 mesh, (ii) a solid/liquid phase transfer catalyst and (iii) a catalytic amount of iodide ions.
2. A process according to claim 1 in which the nonpolar, aprotic organic liquid has a dielectric constant below 5 at 25"C.
3. A process according to either preceding claim in which each ester radical is a C1 -6 alkyl group.
4. A process according to claim 1 in which ethyl acetoacetate and ethyl Ct- chloropropionate or ethyl a-bromopropionate are heated together at 90 to 1100C in a liquid medium containing benzene, toluene or xylene in the presence of potassium carbonate, potassium iodide and tetrabutylammonium bromide. to form diethyl a-acetyl-a'- methylsuccinate.
5. A process according to claim 1 in which ethyl chloropropionate is reacted with ethyl acetoacetate in toluene at 75 to 80"C in the presence of tricaprylyl methylammonium chloride, potassium iodide, and potassium carbonate, milled to a size below 80 mesh, to form diethyl a-acetyl-a'-methylsuccinate.
6. A process according to claim 1 substantially as described in Example 1 or Example 2.
7. A diester of a-acetyl-a'methylsuccinic acid when prepared by a process according to any preceding claim.
8. A process for preparing a diester of a-methyl-å'-acetyl-a'(5-methyl-3-oxohexyl) succinic acid which comprises reacting the cr-acetyl-a'-methylsuccinate diester prepared by a process according to any of claims 1 to 6 with isobutyl vinyl ketone and an alkali metal base in a polar solvent.
9. A process according to claim 8 in which a nonpolar. aprotic organic liquid containing
a di (Cl~,alkyl) ester of Ct-acetvl-ct'-methylsuccinate is reacted with vinyl isobutyl ketone
and a C16 alkanol solution of the base. to form a di(Cl alkyl)a-methyl-a'-(5-methyl-3- oxohexyl) succinate ester.
10. A process according to claim 9 in which a toluene solution of diethyl a-acetyl-a'- methvlsuccinate is reacted with vinyl isobutyl ketone and potassium hydroxide in ethanol.
to form diethvl a-methvl-a'-acetvi-a'-5-methvl-3-oxohexvl) succinate.
11. A process according to any of claims 8 to 10 in which preformed isobutyl vinyl
ketone is added to the mixture containing the a-acetyl-a'-methvlsuccinate diester.
12. A process according to any of claims 8 to 10 in which the isobutyl vinyl ketone is formed in sitit by adding to the mixture containing the u-acetvl-a'-methvls;ccinate diester a N,N-bis(C1 -6 alkyl )-N-(5-methyl-3-oxohexyl) amine, an alkylating agent. deprotonating base and a polar solvent.
13. A process according to claim 8 substantially as described in Example 2 or Example
3.
14. A diester of a-methyl-a'-acetvl-a'-(5methvl-3-oxohexvl) succinic acid when prepared by a process according to any of claims 8 to 13.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77857177A | 1977-03-17 | 1977-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1567444A true GB1567444A (en) | 1980-05-14 |
Family
ID=25113792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB827178A Expired GB1567444A (en) | 1977-03-17 | 1978-03-02 | Preparation of substituted succinic acid esters |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS53116320A (en) |
DE (1) | DE2806424A1 (en) |
FR (1) | FR2383912A1 (en) |
GB (1) | GB1567444A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0022440A1 (en) * | 1979-06-22 | 1981-01-21 | The Upjohn Company | Process for preparing Michael addition products and for converting them to ibuprofen, an anti-inflammatory compound |
-
1978
- 1978-02-15 DE DE19782806424 patent/DE2806424A1/en active Pending
- 1978-03-02 GB GB827178A patent/GB1567444A/en not_active Expired
- 1978-03-16 FR FR7807636A patent/FR2383912A1/en not_active Withdrawn
- 1978-03-17 JP JP3089578A patent/JPS53116320A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2383912A1 (en) | 1978-10-13 |
JPS53116320A (en) | 1978-10-11 |
DE2806424A1 (en) | 1978-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0192849B1 (en) | Process for preparing optically active 2-(4-hydroxyphenoxy)propionic acid compounds | |
Kobayashi et al. | The stereoselective Michael reaction of α, β-unsaturated thioesters with silyl enol ethers promoted by combined use of antimony (V) chloride and tin (II) triflate | |
US4014940A (en) | Process for preparing m-phenoxybenzylalcohol and side-chain halogenated m-phenoxytoluene | |
US4194053A (en) | Process for preparing esters of α-acetyl-α'-methylsuccinic acid and esters of α-methyl-α'-acetyl-α'-(5-methyl-3-oxohexyl)succinic acid | |
GB1567444A (en) | Preparation of substituted succinic acid esters | |
Lansbury | Lithium Aluminum Hydride Reactions in Pyridine Solution. Reductive Cleavage of Ketones1 | |
EP0010859B1 (en) | Process for the preparation of cyclopropane carboxylic acid esters | |
KR950003331B1 (en) | METHOD FOR THE SYNTHESIS OF Ñß-,ÑÔ-UNSATURATED KETONES | |
EP0074272B1 (en) | Process for the preparation of hydroxybenzaldehydes | |
RU2326862C2 (en) | Method of obtaining o-substituted hydroxylamic compounds | |
US4231962A (en) | 3-Phenoxybenzylideneamines and 3-benzylbenzylideneamines | |
EP0825168B1 (en) | Preparation of gamma-halotiglinaldehydes | |
DE69101790T2 (en) | Process for the preparation of vitamin A aldehyde. | |
EP0204736B1 (en) | Process for the preparation of benzene derivatives | |
US4521616A (en) | Method for the preparation of fluoroanthranilic acids | |
EP0037271B1 (en) | Indole derivatives and process for preparing the same | |
US4760169A (en) | Process for the preparation of hydroxymethylenealkoxyacetic acid esters | |
EP0023961B1 (en) | Process for the preparation of sulfur ylide intermediates of insecticidal pyrethroids | |
EP0423991B1 (en) | Process for the preparation of 2-trifluoromethyl-4-hydroxybenzoic acid | |
US4082774A (en) | Methylenedioxybenzene -- improved method of preparation | |
EP0075237A2 (en) | Process for the preparation of 1-formyl-2,6,6-trimethyl-cyclohex-1-ene derivatives | |
SU572449A1 (en) | Method for preparing asymmetric ethers of hemglycols | |
JPH06234785A (en) | Production of 1,2-5,6-diacetone-d-glucose | |
EP0169482B1 (en) | Process for the preparation of 5,6-dihydro-2h-thiopyran-3-carboxaldehydes | |
EP0065356B1 (en) | A method for purification of cyclopentenolones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CSNS | Application of which complete specification have been accepted and published, but patent is not sealed |